Abstract | OBJECTIVES: METHODS: The diagnosis of CDC was based on the criteria proposed by Srigley and Eble. The clinical courses of 5 CDC cases examined in this study suggested that 3 cases were low grade and 2 cases high grade. The expressions of bcl-2, p53 and Ki-67 antigen were evaluated in paraffin-embedded surgical specimens using anti-bcl-2 and anti-p53 antibodies and Ki-67 antigen, respectively. RESULTS: The expression of bcl-2 was recognized in 3 of 5 cases (60%), p53 expression also in 3 of 5 cases (60%). The Ki-67 labeling index was 7.46 +/- 7.40 (mean +/- SD). CONCLUSIONS: It was suggested that there were two clinical types in CDC; the expression of bcl-2 did not correlate with the CDC patients' clinical courses and the cellular proliferation, and p53 expression was recognized in the CDC patients with highly cellular proliferation.
|
Authors | Kazumi Suzuki, Akihiko Tokue |
Journal | Urologia internationalis
(Urol Int)
Vol. 69
Issue 1
Pg. 57-62
( 2002)
ISSN: 0042-1138 [Print] Switzerland |
PMID | 12119441
(Publication Type: Journal Article, Review)
|
Copyright | Copyright 2002 S. Karger AG, Basel |
Chemical References |
- Ki-67 Antigen
- Proto-Oncogene Proteins c-bcl-2
- Tumor Suppressor Protein p53
|
Topics |
- Aged
- Carcinoma, Renal Cell
(metabolism)
- Carcinoma, Transitional Cell
(metabolism)
- Female
- Humans
- Immunohistochemistry
- Ki-67 Antigen
(biosynthesis)
- Kidney Neoplasms
(metabolism)
- Kidney Tubules, Collecting
- Male
- Middle Aged
- Proto-Oncogene Proteins c-bcl-2
(biosynthesis)
- Tumor Suppressor Protein p53
(biosynthesis)
|